Trial intelligence / Profile preview

Pregabalin for Vulvodynia

NCT00853229Phase 2Terminated

Sponsor
Cleveland Clinic
Start
Feb 2009
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pregabalin in vulvodynia, sponsored by Cleveland Clinic. Started Feb 2009; status: terminated.

02

Drugs

pregabalin
03

Conditions

vulvodynia

Beyond the preview

Go deeper on NCT00853229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00853229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call